1982
Grażyna Szwarczyńska, MPharm,
launches production of pharmaceutical
preparations and cosmetics
1982
Grażyna Szwarczyńska, MPharm,
launches production of pharmaceutical
preparations and cosmetics
1988
Biofarm
established as 100%
Polish-owned
partnership
1990
Opening of Biofarm's
drug warehouse
1991
Theospirex retard 300 mg
first drug in production
1995
Wałbrzyska 13 production, laboratories & offices moved to the current location
1996
Ginkofar
our first in-house
development
1998
10th anniversary
119 employees
10 representatives
2001
EU GMP Certificate
(one of the first Polish companies
to achieve this standard)
2002
Biofarm commences export sales
2007
Atrox
- first Polish atrovastatin
2009
Patented Rosuvastatin
formulation - a method preparation
of a pharmaceutical compostition
containing rosuhstatin
2012
Biomentin
first memantine
generic in Europe
2013
We sponsor
Biofarm Basket Poznań team
2016
Biofarm's production so far
22,5 mln packages
700 mln tablets
45 mln capsules
2016
Biofarm becomes a 100% family-owned company
2018
2018
Proaxon
first Polish oseltamivir
in the form of a small tablet
2018
Tamivil
launch of the patented Oseltamivir
formulation in the form of a small tablet
2019
Biotynox Forte
the first drug in Poland with the highest dose of biotin 10 mg
2019
Solicidiol highest
calcifediol dose on
the Polish market
2019
180 products registered in Poland, around 80% developed in-house
2020
During the COVID - 19 pandemic, Biofarm supports pharmacists and doctors by providing disinfectants and personal care products, as well as drug and equipment donations
2020
Launch of Vigalex, Biofarm becomes a Vitamin D3 expert
2020
Launching cooperation with sports clubs across Poland. The company supports healthy competition among children and youth
2022
Rosuvastatin launched in 17 countries
2023
Biofarm's products present on four continents, in 30 countries
2023
35 years of Biofarm's presence on the market